Liuzhou Worker's Hospital

The trials here

What the 11 trials at this site are about, from their registry records.

Conditions

• Stroke2 trials
• Atopic dermatitis (eczema)1 trial
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Hearing loss1 trial
• Heart failure1 trial
• Hepatitis B1 trial
• Liver cirrhosis1 trial
• Multiple myeloma1 trial

Phase

• Phase 36 trials
• Phase 11 trial
• Phase 21 trial

Status

• Not yet recruiting5 trials
• Completed3 trials
• Recruiting3 trials

Lead sponsor

• Akeso1 trial
• Bayer1 trial
• Beijing Tiantan Hospital1 trial
• Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
• Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
• and 6 more

Running trials

• Not yet recruiting

  Clinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response

  NCT07797231· Phase 3· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

  Contact: Qian GUO, Master

• Recruiting

  A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

  NCT07477587· Phase 1· Shanghai Henlius Biotech· Source

  Contact: Yinping Zhong

• Not yet recruiting

  Ongericimab Injection Reducing Recurrence of Ischemic Stroke

  NCT07242599· Phase 3· Beijing Tiantan Hospital· Source

  Contact: Liya Pan

• Recruiting

  Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion

  NCT07185022· The Second Hospital of Anhui Medical University· Source

  Contact: Xianfu Lu

• Recruiting

  Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss

  NCT07505667· Guangdong Provincial People's Hospital· Source

  Contact: ZhuoYi Chen MD

• Not yet recruiting

  A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis

  NCT06767540· Phase 3· Akeso· Source

  Contact: Guoqin Wang

• Recruiting

  Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)

  NCT06569524· Phase 2· Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.· Source

  Contact: Cunli Nong, Master

• Not yet recruiting

  Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

  NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Source

  Contact: Hong Wang

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Stroke2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Coronary artery disease1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Hearing loss1 recruiting
• Hepatitis B1 recruiting
• Multiple myeloma1 recruiting

Closed trials

• Completed

  Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

  NCT05949801· Phase 3· Zensun Sci. & Tech. Co., Ltd.· Source

• Completed

  A Study to Evaluate the Efficacy and Safety of OsrHSA in Patients of Hepatic Cirrhosis With Hypoalbuminemia

  NCT06355479· Phase 3· Healthgen Biotechnology Corp.· Source

• Completed

  A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

  NCT05047263· Phase 3· Bayer· Source